INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING A WRN INHIBITOR, RADIATION THERAPY, CARBOPLATIN AND PACLITAXEL"

GENEVA, Oct. 20 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/053691) for "COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING A WRN INHIBITOR, RADIATION THERAPY, CARBOPLATIN AND PACLITAXEL" on Apr 08, 2025. With publication no. WO/2025/215527, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CORTES-CROS, Marta (c/o Novartis Pharma AGLichtstrasse 354056 Basel), FERRETTI, Stephane (c/o Novartis Pharma AG, NIBR Klybeck Novartis Institutes for Biomed. ResearchKlybeckstrasse 1414057 B...